secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclo Therapeutics, Inc. (—)
CIK:        0000922247
Form:       8-K
Filed at:   2023-03-08T23:59:59+00:00
Accession:  0001437749-23-005797
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclo Therapeutics stockholders approve increase in authorized common shares to 50M
--------------------------------------------------------------------------------

- Stockholders voted to increase authorized common shares from 20M to 50M at Special Meeting on March 3, 2023.
- Proposal passed with 5,712,437 for, 553,794 against, 36,599 abstain; quorum of 63.7% of outstanding shares.
- Certificate of Amendment filed with Nevada Secretary of State on March 7, 2023.
- Company can now issue additional shares, potentially for financing or strategic purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/922247/000143774923005797/0001437749-23-005797-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/922247/000143774923005797/ctdh20230308_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-005797

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer